PFE vs. ORCL
PFE (Pfizer Inc.) and ORCL (Oracle Corporation) are both stocks. PFE operates in Drug Manufacturers - General (Healthcare), while ORCL operates in Software - Infrastructure (Technology). Over the past 10 years, PFE returned 2.11%/yr vs 18.60%/yr for ORCL. At a 0.24 correlation, their price movements are largely independent.
Performance
PFE vs. ORCL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PFE achieves a 8.79% return, which is significantly higher than ORCL's -4.95% return. Over the past 10 years, PFE has underperformed ORCL with an annualized return of 2.11%, while ORCL has yielded a comparatively higher 18.60% annualized return.
PFE
- 1D
- 0.15%
- 1M
- 3.47%
- YTD
- 8.79%
- 6M
- 4.79%
- 1Y
- 14.27%
- 3Y*
- -7.78%
- 5Y*
- -3.35%
- 10Y*
- 2.11%
ORCL
- 1D
- 0.02%
- 1M
- -4.57%
- YTD
- -4.95%
- 6M
- -2.48%
- 1Y
- -13.59%
- 3Y*
- 17.80%
- 5Y*
- 18.90%
- 10Y*
- 18.60%
PFE vs. ORCL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 8.79% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
ORCL Oracle Corporation | -4.95% | 18.13% | 59.99% | 30.94% | -4.65% | 36.89% | 24.25% | 19.34% | -2.97% | 24.94% |
Correlation
The correlation between PFE and ORCL is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Mar 12, 1986 | 0.24 |
The correlation between PFE and ORCL shifts across timeframes, from -0.06 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.
Fundamentals
PFE:
$150.21B
ORCL:
$536.74B
PFE:
$1.31
ORCL:
$5.86
PFE:
19.98
ORCL:
31.41
PFE:
0.36
ORCL:
1.29
PFE:
2.36
ORCL:
7.97
PFE:
1.67
ORCL:
12.47
PFE:
$63.32B
ORCL:
$67.36B
PFE:
$43.91B
ORCL:
$79.58B
PFE:
$16.94B
ORCL:
$6.20B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PFE vs. ORCL — Risk / Return Rank
PFE
ORCL
PFE vs. ORCL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and Oracle Corporation (ORCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PFE | ORCL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.65 | ||
| Sortino ratioReturn per unit of downside risk | +0.66 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.04 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 1.13 | -0.12 | +1.25 |
| Martin ratioReturn relative to average drawdown | 2.27 | -0.20 | +2.47 |
Loading charts...
Drawdowns
PFE vs. ORCL - Drawdown Comparison
The maximum PFE drawdown since its inception was -69.24%, smaller than the maximum ORCL drawdown of -84.19%. Use the drawdown chart below to compare losses from any high point for PFE and ORCL.
Loading charts...
Drawdown Indicators
| PFE | ORCL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.24% | -84.19% | +14.95% |
Max Drawdown (1Y)Largest decline over 1 year | -11.47% | -58.25% | +46.78% |
Max Drawdown (3Y)Largest decline over 3 years | -40.43% | -58.25% | +17.82% |
Max Drawdown (5Y)Largest decline over 5 years | -58.96% | -58.25% | -0.71% |
Max Drawdown (10Y)Largest decline over 10 years | -58.96% | -58.25% | -0.71% |
Current DrawdownCurrent decline from peak | -45.68% | -43.48% | -2.20% |
Average DrawdownAverage peak-to-trough decline | -22.90% | -29.11% | +6.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.70% | 35.41% | -29.71% |
Volatility
PFE vs. ORCL - Volatility Comparison
The current volatility for Pfizer Inc. (PFE) is 5.07%, while Oracle Corporation (ORCL) has a volatility of 23.44%. This indicates that PFE experiences smaller price fluctuations and is considered to be less risky than ORCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PFE | ORCL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.07% | 23.44% | -18.37% |
Volatility (6M)Calculated over the trailing 6-month period | 14.62% | 43.42% | -28.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.84% | 65.91% | -42.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.48% | 42.16% | -16.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.89% | 35.12% | -11.23% |
Dividends
PFE vs. ORCL - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 6.56%, more than ORCL's 1.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ORCL Oracle Corporation | 1.09% | 0.97% | 0.96% | 1.44% | 1.57% | 1.38% | 1.48% | 1.72% | 1.68% | 1.52% | 1.56% | 1.56% |
PFE Pfizer Inc. | 6.56% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
PFE vs. ORCL - Financials Comparison
This section allows you to compare key financial metrics between Pfizer Inc. and Oracle Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PFE and ORCL have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ORCL has higher volatility (23.44%) compared to PFE (5.07%). In terms of maximum drawdown, PFE dropped -69.24% vs ORCL's -84.19%.
PFE currently has the higher Sharpe Ratio (0.54 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PFE and ORCL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer